TherapeuticsMD (NASDAQ: TXMD) — Perfil da empresa, notícias e dados financeiros
TherapeuticsMD focuses on innovating advanced hormone therapy pharmaceuticals exclusively for women's healthcare needs.
TherapeuticsMD
TherapeuticsMD (NASDAQ:TXMD) is a healthcare company focused on creating and commercializing products exclusively for women. With a passionate commitment to women's health, the company's operations primarily revolve around developing and marketing advanced hormone therapy pharmaceuticals designed to address the unique needs of women at various stages of their lives. Their projects span from contraception to post-menopausal treatment alternatives, demonstrating a broad commitment to innovating women's healthcare. Their objective is to continuously explore, understand, and meet the comprehensive healthcare needs of women, offering them safer and more effective therapeutic options. With a keen eye on research and development, TherapeuticsMD aims to lead advancements in female healthcare and improve the quality of life for women worldwide.
Resumo
Operações
Produtos e/ou serviços de TherapeuticsMD
- Annovera: A hormonal contraceptive vaginal ring offering a unique year-long use (13 cycles) with a safety and efficacy profile competitive in the contraceptive space.
- Imvexxy: Low-dose vaginal estrogen capsule designed to treat moderate-to-severe dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy due to menopause, with minimal systemic absorption.
- Bijuva: A hormone therapy combining progesterone and estrogen specifically designed for the treatment of moderate-to-severe vasomotor symptoms due to menopause.
- VitaCare Prescription Services: A bespoke prescription and pharmacy service aiming to provide personalized support, refill reminders, and direct delivery to enhance patient access to medications.
equipe executiva do TherapeuticsMD
- Marlan D. WalkerChief Executive Officer
- Joseph A. ZieglerPrincipal Financial & Accounting Officer
Principais indicadores financeiros
Resultados divulgados pela TherapeuticsMD, em USD.
- Cap. de mercado
- 20,7 mi
- Receita (TTM)
- 3,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -6.6%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 3 mi | -4,2 mi | -569 mil | |
| 1,8 mi | -4,8 mi | -2,2 mi | |
| 1,3 mi | -8,5 mi | -10,3 mi | |
| 70 mi | 10,7 mi | 112 mi |